A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- RANDOMIZED · CROSSOVER · SUPPORTIVE CARE · NONE
- Evidence population
- Human clinical study registration
- Participants
- 34
- Population
- ALL · 50 Years
- Duration
- 2017-09-29 to 2018-04-22
- Intervention
- 8 weeks of circadian adjusted LED-based lighting (CALED)
- Comparator
- Group 1; Group 2; Group 3. Control group
- Outcomes measured
- The average difference in Pittsburgh Sleep Quality Index (PSQI) between the end of the intervention period and the end…; The average difference in plasma soluble urokinase plasminogen receptor (suPAR) between the end of the intervention per…; The average difference in 24-hour mobility between the end of the intervention period and the end of the control period…; The average difference in Epwoth Sleepiness Scale between the end of the intervention period and the end of the control…; The average difference in inflammatory biomarkers such as interleukin (IL)-6, IL-10, soluble CD14, and C reactive prote…; The average difference in endocrinologic biomarkers such as insulin, glucose, cortisol, leptin and melatonin between th…; The average difference in the Mini Mental State Examination between the end of the intervention period and the end of t…; The average difference in the Major Depression Inventory (MDI) between the end of the intervention period and the end o…; The average difference in the Health related quality of life by the EuroQol (EQ-5D-3L) between the end of the intervent…; The average difference in Activities of Daily living by the Barthel 20 index between the end of the intervention period…
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Sleep · 100%Title contains controlled term: circadian. Abstract contains controlled term: sleep, circadian. Source terminology contains: circadian. Title supplies longevity context: elderly. Study type is explicitly identified as INTERVENTIONAL.
Automated source check 100% · update recency 50%. These figures help sort records; they are not medical ratings.
